Purogene Labs Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 2.99 Cr
as on 24-10-2024
- Company Age 25 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 11.23 Cr
as on 24-10-2024
- Revenue -9.29%
(FY 2023)
- Profit 171.99%
(FY 2023)
- Ebitda -0.16%
(FY 2023)
- Net Worth 18.21%
(FY 2023)
- Total Assets -6.20%
(FY 2023)
About Purogene Labs
The Corporate was formerly known as Rchem (Somanahalli) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.99 Cr.
The company has closed loans amounting to ₹11.23 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Annapurna Talluri and Venkata Gopineedi serve as directors at the Company.
- CIN/LLPIN
U02423TG1999PTC086799
- Company No.
086799
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Purogene Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Gopineedi  | Managing Director | 25-Jul-2020 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Annapurna Talluri | Director | 05-Nov-2021 | Current |
Financial Performance of Purogene Labs.
Purogene Labs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.29% decrease. The company also saw a substantial improvement in profitability, with a 171.99% increase in profit. The company's net worth Soared by an impressive increase of 18.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Purogene Labs?
In 2023, Purogene Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹11.23 Cr
Charges Breakdown by Lending Institutions
- Andhra Bank : 10.85 Cr
- Others : 0.38 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Sep 2020 | Others | ₹3.75 M | Satisfied |
| 12 Aug 2015 | Andhra Bank | ₹1.75 Cr | Satisfied |
| 02 Jun 2014 | Andhra Bank | ₹5.00 Cr | Satisfied |
| 23 Feb 2006 | Andhra Bank | ₹4.10 Cr | Satisfied |
How Many Employees Work at Purogene Labs?
Purogene Labs has a workforce of 74 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Purogene Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Purogene Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
